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Dear Editor,
The use of hyperpolarized 13C magnetic resonance to
study intermediary metabolism is increasing rapidly, since
it allows in vivo noninvasive investigation of dynamic
metabolic and physiological processes that were previ-
ously experimentally inaccessible. A recent study pub-
lished in the Journal by Koellish and colleagues used the
technique to address the fate of hyperpolarized 13C-
labeled acetate in STZ-induced diabetic rats (Koellisch
et al. 2015a). While the use of this advanced technology
is welcome, a basic misinterpretation of the cellular meta-
bolic fate of acetate is apparent in the paper (Koellisch
et al. 2015a). In particular, the authors have seriously
misrepresented the mechanism of transfer of the acetate
moiety across the mitochondrial inner membrane, confus-
ing it with the one utilized by long-chain fatty acids, in
which the carnitine palmitoyltransferases (CPT1 and
CPT2) and the inner membrane carrier carnitine acylcar-
nitine translocase (CACT) are crucial (Zammit 1999). In
addition, because of this error, the authors state that car-
nitine acetyltransferase (termed CAT1 by the authors) is
sensitive to malonyl-CoA inhibition. This is not tenable,
as malonyl-CoA inhibition relates solely to carnitine
palmitoyltransferases (CPT1A, CPT1B), and not to car-
nitine acetyltransferase. This basic misunderstanding of
acetate metabolism is also apparent in previous work
published by these authors (Koellisch et al. 2015b).
Carnitine acetyltransferase (generally referred to as
CRAT or CAT) has mitochondrial and peroxisomal iso-
forms (which are not referred to as 1 or 2) and are not
malonyl-CoA sensitive. The formation of the latter is a
diversion of acetyl-CoA formed by b-oxidation of fatty
acids (and other cellular fuels) from oxidation in the tri-
carboxylic acid cycle (Zammit et al. 2009). The pathway:
acetate ? acetyl-CoA ? acetylcarnitine cannot be equa-
ted with the “rate of fatty acid oxidation”, especially when
artificially high levels of acetate are imposed experimen-
tally. The formation of acetylcarnitine has an important
part to play in the regulation of intramitochondrial
acetyl-CoA levels, and, therefore, the balance between glu-
cose and fatty acid utilization by tissues (Zammit et al.
2009). But, rationalization of this role requires knowledge
of the identity, properties and roles of the different mem-
bers of the carnitine acyltransferase family of enzymes,
and specifically, an appropriate distinction between those
that catalyze the utilization of carnitine esters with differ-
ent acyl chain lengths.
In addition, it is noteworthy that parenteral administra-
tion of very high acetate dosages, as used by Koellish et al.,
can be calculated to lead to a plasma exposure of approxi-
mately 10 mmol/L, whereas physiological acetate levels are
usually very much lower in the plasma of mammals
(<0.1 mmol/L) (Veech 1988). Therefore, the protocol used
may have significantly, and nonphysiologically, perturbed
the cellular, and particularly, the intramitochondrial
acetyl-CoA pool (Taegtmeyer et al. 1980). Furthermore,
the severity of the diabetic state induced by the experimen-
tal model (streptozotocin injection) appears to have been
very variable, as the reported blood glucose levels ranged
from 10 to 30 mmol/L (Koellisch et al. 2015a). Assuming
that glycemic levels were obtained in fasted animals (not
stated in the manuscript) such variability may further
hamper the interpretation of the tracer data obtained.
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